| Development of a facile antibody–drug conjugate platform for increased stability and homogeneity N Gupta, J Kancharla, S Kaushik, A Ansari, S Hossain, R Goyal, ... Chemical Science 8 (3), 2387-2395, 2017 | 45 | 2017 |
| Computationally designed antibody–drug conjugates self-assembled via affinity ligands N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ... Nature biomedical engineering 3 (11), 917-929, 2019 | 28 | 2019 |
| A safe and efficacious Pt (ii) anticancer prodrug: design, synthesis, in vitro efficacy, the role of carrier ligands and in vivo tumour growth inhibition PK Dutta, R Sharma, S Kumari, RD Dubey, S Sarkar, J Paulraj, ... Chemical communications 55 (12), 1718-1721, 2019 | 11 | 2019 |
| Targeted drug delivery through affinity based linkers S Sengupta, M Roy, N Gupta, SS Hossain US Patent 10,533,059, 2020 | 4 | 2020 |
| IO-125: A novel supramolecular platinum chemotherapy for triple negative breast cancer. A Sengupta, S Mylavarapu, S Kumari, S Hossain, N Gupta, A Sarkar, ... Journal of Clinical Oncology 33 (28_suppl), 153-153, 2015 | 2 | 2015 |
| IO125, a novel Pt-based supramolecular therapeutic exhibits increased anti-cancer efficacy compared with oxaliplatin M Roy, SS Hossain, A Sarkar, A Sengupta, N Gupta, S Hussain, A Ansari, ... Cancer Research 74 (19_Supplement), 4483-4483, 2014 | 2 | 2014 |
| Computationally designed antibody-drug conjugates self-assembled via affinity ligands (vol 74, pg 502, 2019) N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ... NATURE BIOMEDICAL ENGINEERING, 2020 | 1* | 2020 |
| Author Correction: Computationally designed antibody-drug conjugates self-assembled via affinity ligands. N Gupta, A Ansari, GV Dhoke, M Chilamari, J Sivaccumar, S Kumari, ... Nature biomedical engineering 4 (1), 131, 2020 | 1 | 2020 |
| Supramolecular assembly of antibody-drug conjugates using CORDLink platform for targeted drug delivery N Gupta, J Kancharla, S Kaushik, S Hossain, A Sarkar, A Sengupta, ... Cancer Research 75 (15_Supplement), 649-649, 2015 | 1 | 2015 |
| COMPOUNDS AND METHODS FOR MANAGING CANCER THROUGH IMMUNE SYSTEM H Aggarwal, S Chaubey, R Desikan, N Gupta, S Jain, S Mittal, ... US Patent App. 17/430,849, 2022 | | 2022 |
| COMPOUNDS AND METHODS FOR MANAGING CANCER THROUGH IMMUNE SYSTEM S Sengupta, N Gupta, S Jain, R Desikan, S Mittal, S Chaubey, ... US Patent WO2020168283A1, 2020 | | 2020 |
| Targeted drug delivery through affinity based linkers S Sengupta, M Roy, N Gupta, SS Hossain US Patent App. 16/736,495, 2020 | | 2020 |
| A controlled affinity-guided ADC-linker (MAGNET) technology N Gupta, G Biswas, A Sengupta, M Roy, S Roy, S Sengupta Cancer Research 78 (13_Supplement), 751-751, 2018 | | 2018 |
| Abstract P5-03-03: Designing a novel platinum chemotherapeutic (IO-125) for treatment of breast cancer A Sengupta, M Roy, A Sarkar, S Mylavarapu, S Modi, N Gupta, S Hossain, ... Cancer Research 76 (4_Supplement), P5-03-03-P5-03-03, 2016 | | 2016 |
| PROCESS FOR PREPARING SUPRAMOLECULAR PLATINUM-BASED COMPOUNDS N GUPTA, A SARKAR, H BASSI, P DUTTA WO Patent WO2016185402 A1, 2016 | | 2016 |
| Target (s) of transcriptional regulators ppGpp and DksA N Gupta Rutgers The State University of New Jersey-New Brunswick, 2009 | | 2009 |
